Germany – Services provided by medical laboratories – Next-Generation Sequenzierung von CHIP Mutationen (56 Gen Panel)
Opportunity Score
Confidence: 60%
Complexity: low
8 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This tender by Universitätsklinikum Frankfurt seeks a framework agreement for next-generation sequencing of a 56-gene myeloid panel to detect CHIP mutations in blood samples, including bioinformatic analysis. The estimated volume is 50-500 blood samples per year. The procedure is open, with award based solely on price. Only one lot is defined. Procurement documents are not analyzed, limiting visibility into detailed requirements.
Strengths
Documents available
Open procedure
Low complexity
Risks
Submission deadline in 8 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission is required
- Tenders must be submitted in German language
- Variants are not allowed
Award Criteria
Preis
Preis
| Criterion | Type |
|---|---|
Preis Preis | Price |
Buyer
Name
Universitätsklinikum Frankfurt
Location
Frankfurt am Main, DEU
Website
Identifier
b4de81dd-0ac5-4bd1-9bae-1b5289e7368a
Lots (1)
Framework agreement for next-generation sequencing of a myeloid 56-gene panel in blood samples, including bioinformatic analysis and evaluation, with an estimated 50-500 samples per year.
Procurement Details
Publication
21 May 2026
Deadline
23 Jun 2026, 10:00
Procedure
open
Contract
services
Language
DEU
Publication #
352305-2026
Classification
Performance: Germany
Documents (2)
Opportunity Score
Confidence: 60%
Complexity: low
8 days
Deadline
services
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation